5 studies found

Testing a new drug to prevent Alzheimer's disease and dementia

Do any of your friends, family, or loved ones have problems remembering or have developed Alzheimer’s disease? The USC Alzheimer Disease Research Center is testing how well a drug may help to prevent the loss of memory. The research team is looking for volunteers (ages 60 to 75) who do...


Testing a new drug to reduce anxiety and agitation in people with Alzheimer's disease and dementia

A person with Alzheimer's often feels anxious or upset easily. They might be restless, unable to sleep or pace back and forth. These problems, called agitation, can keep them from a normal day-and-night routine and might become harmful for your loved one or their caregivers.

Can FDA-approved medication that treats...


Diabetes Brain Study: A study to better understand the link between diabetes and brain health

Alzheimer’s disease is a brain disease that affects memory, thinking, and behavior, and causes severe memory loss over time, known as dementia. Diabetes increases the risk of developing Alzheimer’s disease and related dementias. Latinos have a higher risk of developing both diabetes and Alzheimer's but are underrepresented in research. We are studying...


USC GeneScreen: The USC Alzheimer’s Prevention Registry

Researchers at USC invite you, and your friends and family, to enroll online in USC GeneScreen, USC Alzheimer's Prevention Registry.

Alzheimer’s disease is a brain disease that affects memory, thinking, and behavior. It is a progressive brain disorder that causes severe memory loss over time, making it increasingly difficult for people...


Tracking the Risk for Alzheimer’s Disease using the APT Webstudy

The Alzheimer Prevention Trials (APT) Webstudy is designed to accelerate enrollment into Alzheimer’s clinical trials by identifying and tracking individuals online, who may be at higher risk for developing Alzheimer’s. The Alzheimer’s Association estimates that 5.5 million Americans age 65 and older are currently living with Alzheimer’s dementia. It’s believed...